Skip to main content
. 2016 Mar 31;11(3):e0152638. doi: 10.1371/journal.pone.0152638

Table 3. Antibiotic susceptibility profile of NDM-1-producing Enterobacteriaceae with breakpoints (mg/L).

Patient number (organism) AMK (16) ATM (4) FEP (8) FOX (8) CTX (1) TZP (4) CIP (1) CST (2) ETP (0.5) GEN (4) IPM (1) MEM (1) TGC (2)
1 (E. coli) 256 24 64 256 256 256 32 0.5 8 1024 32 32 1
2(M. morgannii) 256 256 256 256 256 256 32 256 4 1024 16 12 4
3(K. pneumoniae) 24 24 256 256 256 256 32 .125 32 0.125 32 32 0.75
4 (E. coli) 256 256 96 256 256 256 >32 0.125 >32 1024 1.5 32 0.25
5(K. pneumoniae) 256 256 256 256 256 256 >32 0.38 >32 512 32 32 1.5
6(K. pneumoniae) 4 64 256 256 256 256 1 0.75 >32 2 >32 >32 1
7 (P. stuartii) 1.5 0.25 0.25 256 256 1.5 1.5 256 3 0.125 1 1.5 2
8(K. pneumoniae) 16 96 256 256 256 256 0.19 0.38 16 1 32 6 0.75
9 (E. coli) 3 0.064 256 256 256 256 >32 0.25 >32 24 4 12 0.5
10 (Enterobacter cloacae) >256 128 32 256 256 256 12 0.38 >32 1024 32 32 3
11(K. pneumoniae) 16 128 64 256 256 256 32 4 >32 3 >32 24 16
12(K. pneumoniae) 16 96 256 256 256 256 32 0.75 32 3 >32 >32 8
13(K. pneumoniae) 256 256 128 256 256 256 16 0.25 >32 512 >32 >32 0.5
14(K. pneumoniae) 128 128 256 256 256 256 32 0.38 >32 64 >32 >32 4
15(K. pneumoniae) 16 128 256 256 256 256 16 0.25 >32 64 16 16 0.5
16 (E. coli) 128 256 256 256 256 256 32 0.38 >32 64 >32 >32 8
17(K. pneumoniae) 32 256 256 256 256 256 32 0.125 >32 0.125 >32 >32 4
18(K. pneumoniae) 64 128 256 256 256 256 16 0.38 >32 64 >32 >32 0.5
19(K. pneumoniae) 32 128 256 256 256 256 32 48 >32 128 >32 >32 16
20(K. pneumoniae) 128 256 256 256 256 256 16 1.5 >32 512 >32 >32 4
21(K. pneumoniae) 64 128 256 256 256 256 32 0.38 >32 128 >32 >32 2

The values in parenthesis in the first row are the recommended breakpoints for resistance according to CLSI [11]. AMK = amikacin; ATM = aztreonam; FEP = cefepime; FOX = cefoxitin; CTX = cefotaxime; TZP = piperacillin-tazobactam; CIP = ciprofloxacin; CST = colistin; ETP = ertapenem; GEN = gentamicin; IPM = imipenem; MEM = meropenem; TGC = tigecycline.